Breaks Categories: News

ThursdayJan 07, 2021 11:46 am

NetworkNewsBreaks – LivePerson Inc. (NASDAQ: LPSN) Closes $517.5M Convertible Senior Notes Offering

LivePerson (NASDAQ: LPSN) has closed its offering of $517.5 million aggregate principal amount of 0% Convertible Senior Notes due 2026 in a private offering pursuant to Rule 144A under the Securities Act of 1933. The notes will have an initial conversion rate of 13.2933 shares of LivePerson common stock per $1,000 principal amount of the notes (subject to adjustment in certain circumstances). This is equivalent to an initial conversion price of approximately $75.23 per share and represents a premium of approximately 42.5% to the $52.79 per share closing price of LivePerson common stock on Dec. 1, 2020. LivePerson intends to…

Continue Reading

ThursdayJan 07, 2021 11:35 am

NetworkNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces Listing on OTC Markets, Now Trading Under PRXT Symbol

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company specializing in cannabis, hemp and mushroom products, recently received approval from OTC Markets and is  now trading under the ticker symbol PRXTF (“PRXTF”). OTC Markets is recognized for offering Canadian companies the benefits of being publicly traded in the United States but with lower cost and complexity than a U.S. exchange listing. To be eligible to list on the OTC Exchange, Canadian companies must undergo an annual verification and management certification process and be up-to-date with their SEDAR reporting. Moving forward, Pure Extracts will continue to trade on…

Continue Reading

ThursdayJan 07, 2021 11:13 am

NetworkNewsBreaks – Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Announces Corporate Name Change, Share Consolidation, Expansions to Its Board and Management

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) today provided a corporate update, including a planned name change, capital consolidation as well as the strengthening of its board of directors and management team. According to the update, the company intends to change its corporate name to Augusta Gold Corp., a consolidation of its capital on the basis of one (1) new share for every six (6) old shares held and a change to its trading symbol to "G" on the Canadian Stock Exchange ("CSE"). "The name change reflects the changes in the management and leadership of the company and…

Continue Reading

ThursdayJan 07, 2021 11:10 am

NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces New VP of Broker and Consultant Partnerships

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has appointed Claudia Rimerman Kraut in the newly created role of vice president of broker and consultant partnerships. Kraut comes to her new responsibilities with impressive senior-management experience at Omada Health, American Well, AIG, United Healthcare and Humana. Kraut will lead Dario's benefit consultant and alliance outreach and be a senior member of DRIO’s employer sales team. Kraut boasts a work record with a unique and notable combination of benefits, partnerships and digital health experience, most recently serving as director of alliances at Omada Health. “We believe that Claudia's deep…

Continue Reading

ThursdayJan 07, 2021 10:45 am

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Biotech Showcase Digital 2021 Conference

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, will be participating in the upcoming Biotech Showcase Digital 2021 conference. The multiday event is scheduled for Jan. 11–15, 2021. As part of the company’s planned participation, AzurRx president and CEO James Sapirstein, along with other members of the senior management team, will attend virtual one-on-one meetings with registered investors and pharmaceutical companies at the prestigious event. During those meetings, the AzurRx representatives will discuss AZRX’s business strategy and clinical-development programs, answer questions and note projected company milestones. To register for the event, visit https://nnw.fm/yTF0e To view…

Continue Reading

ThursdayJan 07, 2021 10:38 am

NetworkNewsBreaks – Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) Appoints New Sr. Director of Sales, Sports and Entertainment

Loop Insights (TSX.V: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence ("AI") to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick-and-mortar space, has named Danny M Spataro as its new director of sales, sports and entertainment; the appointment takes effect Jan. 11, 2021, and is designed to support the company’s recent rapid growth. Spataro comes to the new position with more than a decade of sales and marketing experience and impressive expertise in the collegiate and professional sports spaces. Danny spent 11 years with Learfield IMG College, working closely with Texas A&M,…

Continue Reading

ThursdayJan 07, 2021 10:13 am

NetworkNewsBreaks – Brain Scientific Inc. (BRSF) Releases Disposable Pediatric EEG Headset

Earlier this month, Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, announced that its proprietary NeuroCap(TM) would be available for pediatric patients in the United States. The company noted that the child-sized EEG headset reduces the time typically needed to measure and mark a pediatric patient’s head, as well as for post-test sanitation protocols; the company also observed that the pediatric-sized NeuroCap, designed for use with children aged 2 to 18, could be used in emergency rooms, intensive care units and clinics. A recent “Health Insider” article explained that EEG tests can be required to investigate seizures, sleep…

Continue Reading

ThursdayJan 07, 2021 9:45 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at the H.C. Wainwright BioConnect 2021 Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its CEO, John Climaco, will present at the virtual H.C. Wainwright BioConnect 2021 Conference. The event is slated to be held from Jan. 11-14, 2021, with Climaco’s presentation scheduled for 6:00 a.m. ET on the first day of the event. Interested parties should visit https://nnw.fm/KQtFp to register. The webcast will be available on demand starting at 6:00 a.m. ET on Monday, Jan. 11, 2021. Replays of the presentation will be available…

Continue Reading

WednesdayJan 06, 2021 2:24 pm

NetworkNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Announces DTC Eligibility

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”), dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, today announced that it has obtained eligibility with the Depository Trust Company “DTC” for its common shares listed on the OTCQB. The DTC is a stock depository that facilitates and simplifies electronic trading of securities in the United States. According to the update, Pac Roots common shares, listed on the OTCQB under the symbol PACRF, are now eligible for electronic clearing and settlement through DTC’s automated processes. The electronic method of clearing securities speeds up the receipt of stock and cash…

Continue Reading

WednesdayJan 06, 2021 2:08 pm

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) Releases Report on Patent Filings, Therapeutics Program Development

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, has provided an update on its patent filings. The company has eight filings, all tied to Cybin’s novel therapeutics, delivery mechanisms and treatment regiments. The patent updates noted that Cybin has patent applications for the following: a provisional patent application for an oral film delivery mechanism covering all psychedelic molecules delivered through oral films; a delivery technology covering various chemically synthesized psychedelic molecules; multiple patent applications for deuterated psychedelic molecules and analogues; and a patent application for platforms that create supportive treatment regimens. The company also announced that…

Continue Reading